Evidence map›Paper›PMID 30073631›Full record

ArticleRheumatology and therapy2018

The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study.

Khalid Shirazy, Najia Hajjaj-Hassouni, Constance Hammond, Heather Jones, Aicha Ladjouze Rezig, Ron Pedersen, Bonnie Vlahos

Open access · goldAbstract read
In one paragraph

Article in Rheumatology and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Rheumatic diseases in Africa.Nature reviews. Rheumatology · 2021
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Khalid ShirazyPfizer Inc, Dubai, UAE. shirazyk64@yahoo.com.
Najia Hajjaj-HassouniMohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
Constance HammondPfizer, Collegeville, PA, USA.
Heather JonesPfizer, Collegeville, PA, USA.
Aicha Ladjouze RezigUniversity Hospital Center, Ben Aknoun, Algiers, Algeria.
Ron PedersenPfizer, Collegeville, PA, USA.
Bonnie VlahosPfizer, Collegeville, PA, USA.
Pfizer (United States) · USUniversité Mohammed VI des Sciences de la Santé · MAUniversity Hospital of Oran · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInformation is limited on the prevalence and clinical characteristics of nonradiographic axial spondyloarthritis (nr-axSpA) among patients with inflammatory back pain (IBP) in African countries. A global study estimated the prevalence of nr-axSpA among patients with IBP from 19 countries in Latin America, Europe, Asia, and Africa. This post hoc subset analysis focused on estimating prevalence of nr-axSpA and clinical characteristics among patients with IBP from Northwest Africa (Morocco and Algeria) and South Africa.

methodsPatients from Northwest Africa and South Africa diagnosed with nr-axSpA according to protocol completed patient-reported outcome measures to assess disease activity and functional limitations, including Ankylosing Spondylitis Disease Activity Score (ASDAS).

resultsOf the 206 patients with IBP from Africa (n = 168, Northwest Africa and n = 38, South Africa), 33 (16.0%) were diagnosed with nr-axSpA (n = 26, Northwest Africa and n = 7, South Africa), corresponding to prevalence rates of 15.5% and 18.4%, respectively. Disease activity per region, measured as mean ASDAS, was 2.4 ± 1.4 and 2.4 ± 0.9, respectively, based on erythrocyte sedimentation rate and 2.4 ± 1.3 and 2.7 ± 0.7 based on C-reactive protein.

conclusionsAlthough the number of patients available for the analysis was low, it appears that the prevalence of nr-axSpA among patients with IBP is similar between Northwest and South Africa, and the disease burden is substantial. Limited access to magnetic resonance imaging may hinder early detection in these areas, thereby affecting the assessment of prevalence.

fundingPfizer.

Indexed as

AfricaInflammatory back painNonradiographic axial spondyloarthritisPrevalence

Identifiers

PMID30073631
PMCPMC6251850
OpenAlexW2886537368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.